ELARA Pharmaceuticals
Elarapharma appears to be a pharmaceutical company involved in advanced medical collaborations, including AI-driven precision medicine for cancer patients. However, the domain has expired, and there is limited publicly available information about their specific products, services, or achievements.
Industries
Nr. of Employees
small (1-50)
ELARA Pharmaceuticals
Products
KEM® Explainable Artificial Intelligence (xAI) Platform
A technology that integrates clinical, pre-clinical, and real-world data to design and execute precision medicine clinical trials, identifying optimal doses, patient selection biomarkers, and alternative clinical indications.
Onco KEM®
An oncology therapeutic decision support system that uses clinical data and multi-omic analysis to optimize treatment selection and improve clinical outcomes in cancer therapy.
Precision Medicine Clinical Development
Services that design data-rich clinical protocols using synthetic control arms and stratification biomarkers to accelerate drug development and regulatory approval.
Real World Data & Evidence (RWD/RWE) Platform
A platform that consolidates healthcare admissions databases to support precision medicine clinical development and global health impact evidence generation.
Global Health Impact Evidence Generation
Services that use a cloud analytics platform to conduct epidemiological studies and analyze the medico-economic impact of diseases and industrial activities.
Synthetic Control Arm for Clinical Development
A method that uses curated electronic health records to provide external control for regulatory decision-making in areas of high unmet need.
KEM® Explainable Artificial Intelligence (xAI) Platform
A technology that integrates clinical, pre-clinical, and real-world data to design and execute precision medicine clinical trials, identifying optimal doses, patient selection biomarkers, and alternative clinical indications.
Onco KEM®
An oncology therapeutic decision support system that uses clinical data and multi-omic analysis to optimize treatment selection and improve clinical outcomes in cancer therapy.
Precision Medicine Clinical Development
Services that design data-rich clinical protocols using synthetic control arms and stratification biomarkers to accelerate drug development and regulatory approval.
Real World Data & Evidence (RWD/RWE) Platform
A platform that consolidates healthcare admissions databases to support precision medicine clinical development and global health impact evidence generation.
Global Health Impact Evidence Generation
Services that use a cloud analytics platform to conduct epidemiological studies and analyze the medico-economic impact of diseases and industrial activities.
Synthetic Control Arm for Clinical Development
A method that uses curated electronic health records to provide external control for regulatory decision-making in areas of high unmet need.